HEALTH CATALYST INC (HCAT)

US42225T1079 - Common Stock

6.54  +0.23 (+3.65%)

After market: 6.54 0 (0%)

Full estimates are only available for subscribed users, you can see which data is available below.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2021 2022 2023 2024 2025 2026
Revenue
YoY % growth
241.9M
28.13%		276.2M
14.18%		295.938M
7.15%		316.09M
6.81%
EBITDA
YoY % growth
-78.27M
-4.82%		-86.8M
-10.90%		-44.735M
48.46%		25.159M
156.24%
EBIT
YoY % growth
-115.8M
-23.98%		-135.1M
-16.67%		-86.958M
35.63%		-11.797M
86.43%
Operating Margin
-47.87%-48.91%-29.38%-3.73%
EPS
YoY % growth
-0.43
36.76%		-0.27
37.21%		0.15
155.56%		0.33
117.74%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q1 / 24 Q2 / 24 Q3 / 24 Q4 / 24 Q1 / 25 Q2 / 25 Q3 / 25 Q4 / 25
EPS
Q2Q % growth		0.03
-43.02%
Revenue
Q2Q % growth		76.298M
3.29%
EBITDA
Q2Q % growth		2.975M
EBIT
Q2Q % growth		-5.671M
72.62%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q4 2023
Q2Q % growth		 0.02
140.00%		0.000.022,661.67%
Q3 2023
Q2Q % growth		 0.03
123.08%		-0.020.05272.20%
Q2 2023
Q2Q % growth		 0.05
266.67%		0.000.051,421.28%
Q1 2023
Q2Q % growth		 0.05
183.33%		-0.040.09220.47%
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q4 2023
Q2Q % growth		 75.084M
8.57%		75.076M8K0.01%
Q3 2023
Q2Q % growth		 73.77M
7.93%		74.117M-347K-0.47%
Q2 2023
Q2Q % growth		 73.21M
3.65%		74.087M-877K-1.18%
Q1 2023
Q2Q % growth		 73.87M
8.49%		72.669M1.201M1.65%
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS0% 59.6% 1.95% 45.76%
Revenue-0.37% -6.42% -0.04% -5.53%